Duchenne Muscular Dystrophy
The Duchenne Muscular Dystrophy pipeline: 6 tracked drugs, 1 approved for this indication.
Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Duchenne Muscular Dystrophy, so this list is not complete.
1 approved / phase 41 Phase 31 Phase 2/31 Phase 22 Phase 1/2
Compare the share prices of listed companies in Duchenne Muscular Dystrophy →
Market size not yet sourced. How markets are sized ↗